Nham E, Huh K, Cho S, Chung D, Peck K, Lee N
Infect Chemother. 2020; 52(1):59-69.
PMID: 32239811
PMC: 7113455.
DOI: 10.3947/ic.2020.52.1.59.
Chen I, Lee C, Ting S, Wang L
Infect Drug Resist. 2018; 11:283-293.
PMID: 29535544
PMC: 5840277.
DOI: 10.2147/IDR.S157200.
Meng X, Liu S, Duan J, Huang X, Zhou P, Xiong X
BMC Infect Dis. 2017; 17(1):82.
PMID: 28095785
PMC: 5242049.
DOI: 10.1186/s12879-016-2176-9.
Gomez Rueda V, Zuleta Tobon J
Colomb Med (Cali). 2014; 45(2):54-60.
PMID: 25100889
PMC: 4123582.
Chopra T, Marchaim D, Johnson P, Awali R, Doshi H, Chalana I
Antimicrob Agents Chemother. 2014; 58(8):4630-5.
PMID: 24890594
PMC: 4135982.
DOI: 10.1128/AAC.02441-14.
Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients.
Routsi C, Pratikaki M, Platsouka E, Sotiropoulou C, Papas V, Pitsiolis T
Intensive Care Med. 2013; 39(7):1253-61.
PMID: 23604133
DOI: 10.1007/s00134-013-2914-z.
Multidrug resistant Acinetobacter baumannii: risk factors for appearance of imipenem resistant strains on patients formerly with susceptible strains.
Ye J, Huang C, Shie S, Huang P, Su L, Chiu C
PLoS One. 2010; 5(4):e9947.
PMID: 20369056
PMC: 2846922.
DOI: 10.1371/journal.pone.0009947.
Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
Routsi C, Pratikaki M, Platsouka E, Sotiropoulou C, Nanas S, Markaki V
Infection. 2010; 38(3):173-80.
PMID: 20224962
DOI: 10.1007/s15010-010-0008-1.
Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.
Wener K, Schechner V, Gold H, Wright S, Carmeli Y
Antimicrob Agents Chemother. 2010; 54(5):2010-6.
PMID: 20211888
PMC: 2863615.
DOI: 10.1128/AAC.01131-09.
Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance.
Lautenbach E, Metlay J, Weiner M, Bilker W, Tolomeo P, Mao X
Infect Control Hosp Epidemiol. 2008; 30(1):18-24.
PMID: 19046057
PMC: 2883613.
DOI: 10.1086/592703.
Colonization and persistence of antibiotic-resistant Enterobacteriaceae strains in infants nursed in two neonatal intensive care units in East London, United Kingdom.
Millar M, Philpott A, Wilks M, Whiley A, Warwick S, Hennessy E
J Clin Microbiol. 2007; 46(2):560-7.
PMID: 18039801
PMC: 2238075.
DOI: 10.1128/JCM.00832-07.
Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control study.
Katragkou A, Kotsiou M, Antachopoulos C, Benos A, Sofianou D, Tamiolaki M
Intensive Care Med. 2006; 32(9):1384-91.
PMID: 16788807
DOI: 10.1007/s00134-006-0239-x.
Extended-spectrum beta-lactamases: a clinical update.
Paterson D, Bonomo R
Clin Microbiol Rev. 2005; 18(4):657-86.
PMID: 16223952
PMC: 1265908.
DOI: 10.1128/CMR.18.4.657-686.2005.
Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.
Nouer S, Nucci M, de-Oliveira M, Pellegrino F, Moreira B
Antimicrob Agents Chemother. 2005; 49(9):3663-7.
PMID: 16127037
PMC: 1195411.
DOI: 10.1128/AAC.49.9.3663-3667.2005.
Colonization and resistance dynamics of gram-negative bacteria in patients during and after hospitalization.
Filius P, Gyssens I, Kershof I, Roovers P, Ott A, Vulto A
Antimicrob Agents Chemother. 2005; 49(7):2879-86.
PMID: 15980364
PMC: 1168677.
DOI: 10.1128/AAC.49.7.2879-2886.2005.
Nursing home residents and Enterobacteriaceae resistant to third-generation cephalosporins.
Sandoval C, Walter S, McGeer A, Simor A, Bradley S, Moss L
Emerg Infect Dis. 2004; 10(6):1050-5.
PMID: 15207056
PMC: 3323163.
DOI: 10.3201/eid1006.030662.
Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.
Rodriguez-Bano J, Navarro M, Romero L, Martinez-Martinez L, Muniain M, Perea E
J Clin Microbiol. 2004; 42(3):1089-94.
PMID: 15004058
PMC: 356843.
DOI: 10.1128/JCM.42.3.1089-1094.2004.
Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients.
Weber S, Gold H, Hooper D, Karchmer A, Carmeli Y
Emerg Infect Dis. 2004; 9(11):1415-22.
PMID: 14718085
PMC: 3035560.
DOI: 10.3201/eid0911.030284.
Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study.
Lee S, Kim N, Choi S, Kim T, Chung J, Woo J
Antimicrob Agents Chemother. 2003; 48(1):224-8.
PMID: 14693543
PMC: 310160.
DOI: 10.1128/AAC.48.1.224-228.2004.
Antibiotic use in Hispanic households, New York city.
Larson E, Lin S, Gomez-Duarte C
Emerg Infect Dis. 2003; 9(9):1096-102.
PMID: 14519246
PMC: 2040049.
DOI: 10.3201/eid0909.020371.
